当前位置:首页 - 行情中心 - 悦康药业(688658) - 财务分析 - 现金流量表

悦康药业

(688658)

  

流通市值:60.35亿  总市值:60.35亿
流通股本:4.50亿   总股本:4.50亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,201,763,472.18590,058,926.32,765,240,304.62,002,252,209.14
  收到的税费返还28,706,080.4326,736,747.7334,881,264.446,959,117.17
  收到其他与经营活动有关的现金17,525,093.568,073,438250,546,825.2890,467,494.85
  经营活动现金流入小计1,247,994,646.17624,869,112.033,050,668,394.322,099,678,821.16
  购买商品、接受劳务支付的现金297,414,847.26166,861,367.4785,973,168.51571,785,809.04
  支付给职工以及为职工支付的现金232,398,391.83114,782,275.82429,883,959.77328,971,560.91
  支付的各项税费127,771,801.0959,765,336.34222,789,143.75150,691,224.29
  支付其他与经营活动有关的现金580,889,689.35238,989,881.471,271,735,557.87879,895,937.34
  经营活动现金流出小计1,238,474,729.53580,398,861.032,710,381,829.91,931,344,531.58
  经营活动产生的现金流量净额9,519,916.6444,470,251340,286,564.42168,334,289.58
二、投资活动产生的现金流量:
  收回投资收到的现金357,000,000292,000,000620,000,000310,000,000
  取得投资收益收到的现金3,614,926.891,115,315.683,716,129.192,153,787.03
  处置固定资产、无形资产和其他长期资产收回的现金净额3,013,000-411,135.15107,623.28
  收到的其他与投资活动有关的现金--10,290,706.1410,072,191.78
  投资活动现金流入小计363,627,926.89293,115,315.68634,417,970.48322,333,602.09
  购建固定资产、无形资产和其他长期资产支付的现金50,696,646.8126,163,920.17135,080,502.09116,921,992.41
  投资支付的现金665,666,500505,666,500969,000,000607,000,000
  投资活动现金流出小计716,363,146.81531,830,420.171,104,080,502.09723,921,992.41
  投资活动产生的现金流量净额-352,735,219.92-238,715,104.49-469,662,531.61-401,588,390.32
三、筹资活动产生的现金流量:
  吸收投资收到的现金--100,000100,000
  其中:子公司吸收少数股东投资收到的现金--100,000-
  取得借款收到的现金469,000,000469,000,000122,523,831.62128,588,063.9
  收到其他与筹资活动有关的现金43,000,00020,500,000--
  筹资活动现金流入小计512,000,000489,500,000122,623,831.62128,688,063.9
  偿还债务支付的现金496,868,178.33476,840,000203,119,432.5464,454,741.02
  分配股利、利润或偿付利息支付的现金8,986,900.564,797,359.8423,242,760.0114,854,094.61
  支付其他与筹资活动有关的现金1,795,362.91,355,144.018,316,156.7372,695,116.54
  筹资活动现金流出小计507,650,441.79482,992,503.85234,678,349.28152,003,952.17
  筹资活动产生的现金流量净额4,349,558.216,507,496.15-112,054,517.66-23,315,888.27
四、汇率变动对现金及现金等价物的影响-262,694.12-64,600.84137,936.78169,760.33
五、现金及现金等价物净增加额-339,128,439.19-187,801,958.18-241,292,548.07-256,400,228.68
  加:期初现金及现金等价物余额996,526,592.73996,526,592.731,237,819,140.81,237,819,140.8
  期末现金及现金等价物余额657,398,153.54808,724,634.55996,526,592.73981,418,912.12
补充资料:
  净利润-120,440,561.9--274,816,190.81-
  资产减值准备70,280,994.8-41,543,453.77-
  固定资产和投资性房地产折旧86,902,726.27-172,979,861.81-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧86,902,726.27-172,979,861.81-
  无形资产摊销14,223,812.88-27,927,366.16-
  长期待摊费用摊销2,942,396.58-4,974,805.2-
  处置固定资产、无形资产和其他长期资产的损失270,846.96--924,147.58-
  固定资产报废损失18,317.92-2,462,357.76-
  公允价值变动损失-1,284,430.91--6,040,391.9-
  财务费用8,459,985.72-21,274,333.28-
  投资损失-2,965,793.86--3,461,129.19-
  递延所得税788,591.87-32,580,588.91-
  其中:递延所得税资产减少632,855.29-25,485,671.53-
    递延所得税负债增加155,736.58-7,094,917.38-
  存货的减少63,385,175.59-266,707,678.3-
  经营性应收项目的减少-42,551,244.04-208,186,369.86-
  经营性应付项目的增加-73,058,846.17--156,762,709.91-
  现金的期末余额657,398,153.54-996,526,592.73-
  减:现金的期初余额996,526,592.73-1,237,819,140.8-
  现金及现金等价物的净增加额-339,128,439.19--241,292,548.07-
公告日期2026-08-212026-04-302026-03-212025-10-30
审计意见(境内)标准无保留意见
TOP↑